| Literature DB >> 27463966 |
Shih-Chi Su1,2, Ming-Ju Hsieh3,4,5, Yu-Fan Liu6,7, Ying-Erh Chou7,8, Chiao-Wen Lin9,10, Shun-Fa Yang3,7.
Abstract
BACKGROUND: Oral cancer is a common malignancy that is shown to be causally associated with hereditary and acquired factors. ADAMTS14 is a member of the ADAMTS (a disintegrin-like and metalloproteinase domain with thrombospondin motifs) metalloproteinase family that plays an important role in extracellular matrix (ECM) assembly and degradation. Elevation or deficiency of certain ADAMTS proteinases has been known to be implicated in a wide range of pathological processes including atherosclerosis, arthritis, and cancer. The present study aimed to explore the impact of ADAMTS14 gene polymorphisms, combined with environmental risks on the susceptibility to oral tumorigenesis. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2016 PMID: 27463966 PMCID: PMC4962993 DOI: 10.1371/journal.pone.0159585
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
ADAMTS14 gene polymorphisms assessed in this study.
| Variable | Exon (contiguous position) | |||
|---|---|---|---|---|
| Chromosome | 10:70741007 | 10:70753879 | 10:70758253 | 10:70760503 |
| Exon | 12 | 19 | 21 | 22 |
| cDNA position & nucleotide change | c.1778T>C | c.2818C>A | c.3155A>G | c.3331C>T |
| Protein position | 593 | 940 | 1052 | 1111 |
| dbSNP rs No. | rs10823607 | rs12774070 | rs4747096 | rs61573157 |
| Function | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous |
| dbSNP allele | CTG>CGG | CTG>ATG | GAA>GGA | CCA>TCA |
| Protein residue | L [Leu] >P [Pro] | L [Leu] >M [Met] | E [Glu]> G [Gly] | P [Pro]> S [Ser] |
| Codon position | 2 | 1 | 2 | 1 |
╪: NM_139155.2
†: NP_631894.2.
The distributions of demographical characteristics in 1200 male controls and 850 male patients with oral cancer.
| Variable | Controls (N = 1200) | Patients (N = 850) | |
|---|---|---|---|
| Age (yrs) | Mean ± S.D. | Mean ± S.D. | |
| 53.91 ± 10.02 | 54.60 ± 11.09 | ||
| Betel quid chewing | |||
| No | 1001 (83.4%) | 156 (18.4%) | |
| Yes | 199 (16.6%) | 694 (81.6%) | |
| Cigarette smoking | |||
| No | 564 (47.0%) | 85 (10.0%) | |
| Yes | 636 (53.0%) | 765 (90.0%) | |
| Alcohol drinking | |||
| No | 963 (80.3%) | 357 (42.0%) | |
| Yes | 237 (19.7%) | 493 (58.0%) | |
| Stage | |||
| I+II | 412 (48.5%) | ||
| III+IV | 438 (51.5%) | ||
| Tumor T status | |||
| T1+T2 | 489 (57.5%) | ||
| T3+T4 | 361 (42.5%) | ||
| Lymph node status | |||
| N0 | 570 (67.1%) | ||
| N1+N2+N3 | 280 (32.9%) | ||
| Metastasis | |||
| M0 | 841 (98.9%) | ||
| M1 | 9 (1.1%) | ||
| Cell differentiation | |||
| Well differentiated | 141 (16.6%) | ||
| Moderately or poorly differentiated | 709 (83.4%) |
Parametric independent t-test was used between healthy controls and patients with oral cancer.
* p value < 0.05 as statistically significant.
Distributions of genotypic frequencies of ADAMTS14 SNPs in controls and oral cancer patients.
| Variable | Controls (N = 1200) n (%) | Patients (N = 850) n (%) | OR (95% CI) | AOR (95% CI) |
|---|---|---|---|---|
| CC | 1017 (84.7%) | 714 (84.0%) | 1.00 | 1.00 |
| CT | 175 (14.6%) | 132 (15.5%) | 1.07 (0.84–1.37) | 1.03 (0.74–1.42) |
| TT | 8 (0.7%) | 4 (0.5%) | 0.71 (0.21–2.37) | 0.80 (0.15–4.18) |
| CT+TT | 183 (15.3%) | 136 (16.0%) | 1.06 (0.83–1.35) | 1.02 (0.74–1.40) |
| CC | 876 (73.0%) | 616 (72.5%) | 1.00 | 1.00 |
| CA | 290 (24.2%) | 219 (25.8%) | 1.07 (0.88–1.32) | 1.06 (0.81–1.39) |
| AA | 34 (2.8%) | 15 (1.8%) | 0.63 (0.34–1.16) | 0.47 (0.21–1.07) |
| CA+AA | 324 (27.0%) | 234 (27.5%) | 1.03 (0.84–1.25) | 0.99 (0.76–1.29) |
| AA | 489 (40.8%) | 360 (42.4%) | 1.00 | 1.00 |
| AG | 568 (47.3%) | 384 (45.2%) | 0.92 (0.76–1.11) | 1.00 (0.78–1.29) |
| GG | 143 (12.0%) | 106 (12.5%) | 1.01 (0.76–1.34) | 1.19 (0.81–1.75) |
| AG+GG | 711 (59.3%) | 490 (57.6%) | 0.94 (0.78–1.12) | 1.04 (0.82–1.32) |
| CC | 995 (82.9%) | 702 (82.6%) | 1.00 | 1.00 |
| CT | 194 (16.2%) | 141 (16.6%) | 1.03 (0.81–1.31) | 1.03 (0.75–1.41) |
| TT | 11 (0.9%) | 7 (0.8%) | 0.90 (0.35–2.34) | 1.31 (0.36–4.85) |
| CT+TT | 205 (17.1%) | 148 (17.4%) | 1.02 (0.81–1.29) | 1.04 (0.76–1.42) |
The odds ratio (OR) with their 95% confidence intervals were estimated by logistic regression models.
The adjusted odds ratio (AOR) with their 95% confidence intervals were estimated by multiple logistic regression models after controlling for betel nut chewing, alcohol and tobacco consumption.
Associations of combined effects of ADAMTS14 genotypic frequencies and betel nut chewing with oral cancer among 1401 smokers.
| Variable | Controls (n = 636) (%) | Patients (n = 765) (%) | OR (95% CI) | AOR (95% CI) |
|---|---|---|---|---|
| 372 (58.5%) | 91 (11.9%) | 1.00 | 1.00 | |
| 77 (12.1%) | 13 (1.7%) | 0.70 (0.37–1.30) | 0.54 (0.26–1.13) | |
| 160 (25.2) | 556 (72.7%) | |||
| 27 (4.2%) | 105 (13.7%) | |||
| 326 (51.3%) | 75 (9.8%) | 1.00 | 1.00 | |
| 123 (19.3%) | 29 (3.8%) | 1.03 (0.64–1.65) | 0.89 (0.51–1.55) | |
| 137 (21.5%) | 478 (62.5%) | |||
| 50 (7.9%) | 183 (23.9%) | |||
| 190 (29.9%) | 36 (4.7%) | 1.00 | 1.00 | |
| 259 (40.7%) | 68 (8.9%) | 1.39 (0.89–2.16) | 1.33 (0.80–2.22) | |
| 73 (11.5%) | 293 (38.3%) | |||
| 114 (17.9%) | 368 (48.1%) | |||
| 375 (59.0%) | 79 (10.3%) | 1.00 | 1.00 | |
| 74 (11.6%) | 25 (3.3%) | 1.60 (0.96–2.68) | 1.58 (0.86–2.89) | |
| 152 (23.9%) | 549 (71.8%) | |||
| 35 (5.5%) | 112 (14.6%) |
The odds ratios (ORs) with their 95% confidence intervals were estimated by logistic regression models.
The adjusted odds ratios (AORs) with their 95% confidence intervals were estimated by multiple logistic regression models after controlling for age and alcohol consumption.
a Individual with wild-type genotype but without betel nut chewing.
b Individual with either at least one minor allele without betel nut chewing.
c Individual with wild-type genotype and betel nut chewing.
d Individual with both at least one minor allele and betel nut chewing.
Associations of genotype frequencies of ADAMTS14 rs12774070 with clinical status of oral cancer among 694 betel quid users.
| Variable | ||||
|---|---|---|---|---|
| CC (n = 503) n (%) | CA+AA (n = 191) n (%) | OR (95% CI) | AOR (95% CI) | |
| Stage I/II | 248 (49.3%) | 91 (47.6%) | 1.00 | 1.00 |
| Stage III/IV | 255 (50.7%) | 100 (52.4%) | 1.07 (0.77–1.49) | 1.10 (0.77–1.58) |
| ≤T2 | 288 (57.3%) | 109 (57.1%) | 1.00 | 1.00 |
| > T2 | 215 (42.7%) | 82 (42.9%) | 1.01 (0.72–1.41) | 1.07 (0.75–1.54) |
| No | 339 (67.4%) | 127 (66.5%) | 1.00 | 1.00 |
| Yes | 164 (32.6%) | 64 (33.5%) | 1.04 (0.73–1.45) | 1.08 (0.73–1.56) |
| well | 79 (15.7%) | 44 (23.0%) | 1.00 | 1.00 |
| Moderate/poor | 424 (84.3%) | 147 (77.0%) | ||
The adjusted odds ratios (AORs) with their 95% confidence intervals were estimated by multiple logistic regression models after controlling for age, alcohol and tobacco consumption.
*p<0.05.
Fig 1Functional implication and In silico profiling of ADAMTS14 SNP rs12774070.
(A) ADAMTS14 displays a significant eQTL association with rs12774070 genotypes in esophagus mucosa tissues (GTEx data set). (B) The altered residue is conserved throughout three procollagen aminopropeptidase subfamily of ADAMTS proteases, including ADAMTS2 (NP_055059.2), ADAMTS3 (NP_055058.2) and ADAMTS14 (NP_631894.2), as shown by alignment of the protein sequences with Crustal Omega software. Numbering is for human ADMDTS14. The arrow represents b-strands, and consensus sites for N-liked oligosaccharide attachment are marked in red (pinpointed). The disulfide bonds are marked in dark lines connecting paired cysteines. (C) Schematic representation of the full-length human ADMDTS14 protein, domain symbols are drawn approximately to scale. The rectangles represent the key domain structures, ZnMc superfamily (cd04273; pink), ADAM spacer1 (pfam05986; green) and four TSR1 (smart00209; yellow) by NCBI CDD server. Putative furin cleavage site is indicated by an arrowhead, and N-linked glycosylation sites are pointed by pins. (D) Ribbon diagram depicts the homology model of TSR1 (3) domain of ADAMTS14. The ribbon indicates the Cα carbon of the TSR1 domain characterized in this study. The blue ribbon, purple sphere, green spheres and yellow sticks indicate the b-strands structure, SNP rs12774070, potential N-linked glycosylation site and disulfide bonds, respectively. (E) Pathogenicity prediction of ADAMTS14 SNPs assessed in this study.